(Q54107477)

24 May 2018

title

In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. (English)

1 reference

24 May 2018

author name string

Kunimoto DY

1

1 reference

24 May 2018

Sharma S

2

1 reference

24 May 2018

Garg P

3

1 reference

24 May 2018

Rao GN

4

1 reference

24 May 2018

publication date

1 January 1999

1 reference

24 May 2018

published in

Ophthalmology

1 reference

24 May 2018

volume

106

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

80-85

1 reference

24 May 2018

0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

The Stability of Ten Antibiotics in Artificial Tear Solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Fluoroquinolones in the treatment of bacterial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Ciprofloxacin-resistant bacterial keratitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Ciprofloxacin-resistant bacterial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Differential care of corneal ulcers in the community based on apparent severity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

The mode of action of 4-quinolones and possible mechanisms of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990008-8

7 January 2021

10.1016/S0161-6420(99)90008-8

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018